Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Disease/ Diagnostics

show results
Refine your search

Search term:

Results 1 - 5 of 5
EC Number Disease PubMed ID Title of Publication Category Confidence Level
Show all pathways known for 2.1.3.1Display the word mapDisplay the reaction diagram Show all sequences 2.1.3.1Carcinoma 28270654 A Proposed Physiopathological Pathway to Hyperammonemic Encephalopathy in a Non-Cirrhotic Patient with Fibrolamellar Hepatocellular Carcinoma without Ornithine Transcarbamylase (OTC) Mutation. causal interaction
therapeutic application
unassigned
3
1
0
Show all pathways known for 2.1.3.1Display the word mapDisplay the reaction diagram Show all sequences 2.1.3.1Carcinoma, Ehrlich Tumor 6508821 Binding of radiolabeled N-(phosphonacetyl)-L-aspartate to aspartate transcarbamylase from Ehrlich ascites tumor cells. diagnostic usage
ongoing research
unassigned
3
1
0
Show all pathways known for 2.1.3.1Display the word mapDisplay the reaction diagram Show all sequences 2.1.3.1methylmalonyl-coa carboxytransferase deficiency 33279518 Development of Gene Therapy Vectors: Remaining Challenges. causal interaction
therapeutic application
unassigned
1
4
0
Show all pathways known for 2.1.3.1Display the word mapDisplay the reaction diagram Show all sequences 2.1.3.1Neoplasms 6508821 Binding of radiolabeled N-(phosphonacetyl)-L-aspartate to aspartate transcarbamylase from Ehrlich ascites tumor cells. diagnostic usage
ongoing research
unassigned
3
1
0
Show all pathways known for 2.1.3.1Display the word mapDisplay the reaction diagram Show all sequences 2.1.3.1Urea Cycle Disorders, Inborn 28270654 A Proposed Physiopathological Pathway to Hyperammonemic Encephalopathy in a Non-Cirrhotic Patient with Fibrolamellar Hepatocellular Carcinoma without Ornithine Transcarbamylase (OTC) Mutation. causal interaction
therapeutic application
unassigned
3
1
0
Results 1 - 5 of 5